Spiro Gavaris | Association for Accessible Medicines
AAM All Access Podcast - Featuring AAM CEO Dan Leonard and Apotex President and CEO Jeff Watson

Spiro Gavaris

AAM Board Member
President, Specialty Generics, Mallinckrodt Specialty Generics
Spiro Gavaris
Spiro Gavaris
Mallinckrodt Specialty Generics

Spiro Gavaris is the President, Specialty Generics, at Mallinckrodt Pharmaceuticals. He has responsibility for the company’s specialty generics, active pharmaceutical ingredients and non-promoted brands products, and is a member of Mallinckrodt’s senior leadership team.

Previously, Spiro served as president of the U.S. Injectables division of Hikma. Spiro also served as a practice executive at Campbell Alliance consulting firm, working with pharmaceutical, biotech, animal health and device companies. He entered the pharmaceuticals industry in sales for Bristol Myers-Squib after working as a civil engineer.

Spiro holds a bachelor’s degree from Franklin and Marshall College and an MBA in marketing and management from New York University, Stern School of Business.​

Latest Tweets

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.